Skip to main content
Top
Published in: Digestive Diseases and Sciences 8/2022

13-08-2021 | Acetylsalicylic Acid | Original Article

Predictive Value of Genetic Risk Scores in the Development of Colorectal Adenomas

Authors: Carla J. Gargallo-Puyuelo, Rocío Aznar-Gimeno, Patricia Carrera-Lasfuentes, Ángel Lanas, Ángel Ferrández, Enrique Quintero, Marta Carrillo, Inmaculada Alonso-Abreu, Luis M. Esteban, María de la Vega Rodrigálvarez-Chamarro, Rafael del Hoyo-Alonso, María Asunción García-González

Published in: Digestive Diseases and Sciences | Issue 8/2022

Login to get access

Abstract

Introduction

Unlike colorectal cancer (CRC), few studies have explored the predictive value of genetic risk scores (GRS) in the development of colorectal adenomas (CRA), either alone or in combination with other demographic and clinical factors.

Methods

In this study, genomic DNA from 613 Spanish Caucasian patients with CRA and 829 polyp-free individuals was genotyped for 88 single-nucleotide polymorphisms (SNPs) associated with CRC risk using the MassArray™ (Sequenom) platform. After applying a multivariate logistic regression model, five SNPs were selected to calculate the GRS. Regression models adjusted by sex, age, family history of CRC, chronic use of NSAIDs, low-dose ASA, and consumption of tobacco were built in order to study the association between GRS and CRA risk. We evaluated the discriminatory capacity using the area under the receiver operating characteristic curve (AUC). The interactions between demographic information and GRS were also analyzed.

Results

Significant associations between high GRS values and risk of CRA for analyzed models were observed. In particular, patients with higher GRS values had 2.3–2.6-fold increase in risk of CRA compared to patients with middle values. Combining sex and age with the GRS significantly increased the discriminatory accuracy of the univariate model with GRS alone. The best model achieved an AUC value of 0.665 (95% CI: 0.63–0.69). The GRS showed a different behavior depending on sex and age.

Conclusion

Our findings showed that, besides sex and age, GRS is an important risk factor for development of CRA and may be useful for CRC risk stratification and adaptation of screening programs.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRef Bray F, Ferlay J, Soerjomataram I et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.CrossRef
2.
go back to reference Huyghe JR, Bien SA, Harrison TA et al. Discovery of common and rare genetic risk variants for colorectal cancer. NatGenet. 2019;51:76–87. Huyghe JR, Bien SA, Harrison TA et al. Discovery of common and rare genetic risk variants for colorectal cancer. NatGenet. 2019;51:76–87.
3.
go back to reference Schmit SL, Edlund CK, Schumacher FR et al. Novel common genetic susceptibility loci for colorectal cancer. J Natl Cancer Inst. 2019;1:146–157.CrossRef Schmit SL, Edlund CK, Schumacher FR et al. Novel common genetic susceptibility loci for colorectal cancer. J Natl Cancer Inst. 2019;1:146–157.CrossRef
4.
go back to reference Law PJ, Timofeeva M, Fernandez-Rozadilla C et al. Association analyses identify 31 new risk loci for colorectal cancer susceptibility. NatCommun. 2019;14:2154. Law PJ, Timofeeva M, Fernandez-Rozadilla C et al. Association analyses identify 31 new risk loci for colorectal cancer susceptibility. NatCommun. 2019;14:2154.
5.
go back to reference Jeon J, Du M, Schoen RE et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology. 2018;154:2152-2164.e19.CrossRef Jeon J, Du M, Schoen RE et al. Determining risk of colorectal cancer and starting age of screening based on lifestyle, environmental, and genetic factors. Gastroenterology. 2018;154:2152-2164.e19.CrossRef
6.
go back to reference Weigl K, Thomsen H, Balavarca Y et al. Genetic risk score is associated with prevalence of advanced neoplasms in a colorectal cancer screening population. Gastroenterology. 2018;155:88-98.e10.CrossRef Weigl K, Thomsen H, Balavarca Y et al. Genetic risk score is associated with prevalence of advanced neoplasms in a colorectal cancer screening population. Gastroenterology. 2018;155:88-98.e10.CrossRef
7.
go back to reference Weigl K, Chang-Claude J, Knebel P et al. Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score. ClinEpidemiol. 2018;10:143–152. Weigl K, Chang-Claude J, Knebel P et al. Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score. ClinEpidemiol. 2018;10:143–152.
8.
go back to reference Hsu L, Jeon J, Brenner H et al. A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology. 2015;148:1330–9.e14.CrossRef Hsu L, Jeon J, Brenner H et al. A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology. 2015;148:1330–9.e14.CrossRef
9.
go back to reference Ibáñez-Sanz G, Díez-Villanueva A, Alonso MH et al. Risk model for colorectal cancer in Spanish population using environmental and genetic factors: results from the MCC-Spain study. Sci Rep. 2017;24:43263.CrossRef Ibáñez-Sanz G, Díez-Villanueva A, Alonso MH et al. Risk model for colorectal cancer in Spanish population using environmental and genetic factors: results from the MCC-Spain study. Sci Rep. 2017;24:43263.CrossRef
10.
go back to reference Gargallo CJ, Lanas Á, Carrera-Lasfuentes P et al. Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer. Int J Cancer. 2019;144:489–502.CrossRef Gargallo CJ, Lanas Á, Carrera-Lasfuentes P et al. Genetic susceptibility in the development of colorectal adenomas according to family history of colorectal cancer. Int J Cancer. 2019;144:489–502.CrossRef
11.
go back to reference Pepe MS, Longton G, Janes H. Estimation and comparison of receiver operating characteristic curves. Stata J. 2009;9:1.CrossRef Pepe MS, Longton G, Janes H. Estimation and comparison of receiver operating characteristic curves. Stata J. 2009;9:1.CrossRef
12.
13.
go back to reference Kundu S, Aulchenko YS, van Duijn CM, Janssens ACJ. PredictABEL: an R package for the assessment of risk prediction models. Eur J Epidemiol. 2011;26:261.CrossRef Kundu S, Aulchenko YS, van Duijn CM, Janssens ACJ. PredictABEL: an R package for the assessment of risk prediction models. Eur J Epidemiol. 2011;26:261.CrossRef
14.
go back to reference Cubiella J, Marzo-Castillejo M, Mascort-Roca JJ et al. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 20187 Update. GastroenterolHepatol. 2018;41:585–596. Cubiella J, Marzo-Castillejo M, Mascort-Roca JJ et al. Clinical practice guideline. Diagnosis and prevention of colorectal cancer. 20187 Update. GastroenterolHepatol. 2018;41:585–596.
15.
go back to reference Rex DK, Boland CR, Dominitz JA et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;112:1016–1030.CrossRef Rex DK, Boland CR, Dominitz JA et al. Colorectal cancer screening: recommendations for physicians and patients from the U.S. multi-society task force on colorectal cancer. Am J Gastroenterol. 2017;112:1016–1030.CrossRef
16.
go back to reference Abulí A, Castells A, Bujanda L et al. PROCOLON researchgroup. Genetic variants associated with colorectal adenoma susceptibility. PLoS One. 2016;11:e0153084.CrossRef Abulí A, Castells A, Bujanda L et al. PROCOLON researchgroup. Genetic variants associated with colorectal adenoma susceptibility. PLoS One. 2016;11:e0153084.CrossRef
17.
go back to reference Dunlop MG, Tenesa A, Farrington SM et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals. Gut. 2013;62:871–881.CrossRef Dunlop MG, Tenesa A, Farrington SM et al. Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals. Gut. 2013;62:871–881.CrossRef
18.
go back to reference Yarnall JM, Crouch DJ, Lewis CM. Incorporating non-genetic risk factors and behavioural modifications into risk prediction models for colorectal cancer. Cancer Epidemiol. 2013;37:324–329.CrossRef Yarnall JM, Crouch DJ, Lewis CM. Incorporating non-genetic risk factors and behavioural modifications into risk prediction models for colorectal cancer. Cancer Epidemiol. 2013;37:324–329.CrossRef
19.
go back to reference Balavarca Y, Weigl K, Thomsen H, Brenner H. Performance of individual and joint risk stratification by an environmental risk score and a genetic risk score in a colorectal cancer screening setting. Int J Cancer. 2020;146:627–634.CrossRef Balavarca Y, Weigl K, Thomsen H, Brenner H. Performance of individual and joint risk stratification by an environmental risk score and a genetic risk score in a colorectal cancer screening setting. Int J Cancer. 2020;146:627–634.CrossRef
20.
go back to reference Zhang B, Shrubsole MJ, Li G et al. Association of genetic variants for colorectal cancer differs by subtypes of polyps in the colorectum. Carcinogenesis. 2012;33:2417–2423.CrossRef Zhang B, Shrubsole MJ, Li G et al. Association of genetic variants for colorectal cancer differs by subtypes of polyps in the colorectum. Carcinogenesis. 2012;33:2417–2423.CrossRef
21.
go back to reference Nguyen SP, Bent S, Chen YH, Terdiman JP. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:676-81.e1–3.CrossRef Nguyen SP, Bent S, Chen YH, Terdiman JP. Gender as a risk factor for advanced neoplasia and colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2009;7:676-81.e1–3.CrossRef
22.
go back to reference Kolligs FT, Crispin A, Munte A et al. Risk of advanced colorectal neoplasia according to age and gender. PLoS One. 2011;6:e20076.CrossRef Kolligs FT, Crispin A, Munte A et al. Risk of advanced colorectal neoplasia according to age and gender. PLoS One. 2011;6:e20076.CrossRef
23.
go back to reference Ferlitsch M, Reinhart K, Pramhas S et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA. 2011;306:1352–1358.CrossRef Ferlitsch M, Reinhart K, Pramhas S et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA. 2011;306:1352–1358.CrossRef
Metadata
Title
Predictive Value of Genetic Risk Scores in the Development of Colorectal Adenomas
Authors
Carla J. Gargallo-Puyuelo
Rocío Aznar-Gimeno
Patricia Carrera-Lasfuentes
Ángel Lanas
Ángel Ferrández
Enrique Quintero
Marta Carrillo
Inmaculada Alonso-Abreu
Luis M. Esteban
María de la Vega Rodrigálvarez-Chamarro
Rafael del Hoyo-Alonso
María Asunción García-González
Publication date
13-08-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 8/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07218-5

Other articles of this Issue 8/2022

Digestive Diseases and Sciences 8/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.